The combination of cyclic peptides and hydrogel technology is a potential strategy for increasing wound healing, especially for chronic wounds that do not heal with standard methods. However, stability, manufacturing, and regulatory issues must be overcome before widespread clinical use can occur. Future research directions include personalized approaches, integration with cell therapies, and mechanistic studies to improve the efficacy of these wound-healing systems.
Shahjad et al. (Tue,) studied this question.